---
title: "Why Is WORK Medical Technology Stock Falling On Wednesday?"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286257446.md"
description: "WORK Medical Technology Group Ltd (NASDAQ: WOK) shares fell on Wednesday after a 69% surge earlier in the week, driven by profit-taking and volatility. The stock peaked at $11.30 following a deal with Shanghai Novabioplus Biotechnology. Currently, WOK is trading at $1.33, down 80.03% in premarket, and remains significantly below its 200-day SMA. Key resistance is at $3, while support is at $1.99. The RSI is at 96.77, indicating strong momentum but mixed moving-average signals."
datetime: "2026-05-13T11:55:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286257446.md)
  - [en](https://longbridge.com/en/news/286257446.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286257446.md)
---

# Why Is WORK Medical Technology Stock Falling On Wednesday?

**WORK Medical Technology Group Ltd** (NASDAQ:WOK) shares are trading lower on Wednesday. The decline follows extreme volatility and intense profit-taking following a massive, news-driven rally earlier in the week.

## Volatility Hits Post-Rally Highs

The Hangzhou-based supplier saw shares spike 69.67% to $11.30 during Tuesday’s session. Traders are now cooling off after that rapid ascent.

The initial rally stemmed from a deal with **Shanghai Novabioplus Biotechnology Co., Ltd.** The agreement focuses on a “Data-Model-Application” trinity, which the Management calls a “significant milestone” for their digital ecosystem evolution.

## Digital Assets and BioToken Framework

WOK is developing a BioToken framework to digitize biopharmaceutical research and development outputs. This model mirrors their existing real-world assets (RWA) strategy. Projects include antibody sequence optimization and enzyme molecule design.

## WOK Technical Levels To Watch After Recent Pullback

From a trend perspective, WOK is still trading 77.5% above its 20-day SMA of $1.64 and 115.8% above its 50-day SMA of $1.35. At the same time, it remains 99.8% below its 200-day SMA of $1776.14.

Momentum is the key story: RSI is at 96.77.

The moving-average structure is mixed: the 20-day SMA is above the 50-day SMA (a bullish near-term crossover), but the 50-day SMA is still below the 200-day SMA (a bearish longer-term alignment).

-   **Key Resistance**: $3
-   **Key Support**: $1.99

**WOK Price Action:** WORK Medical shares were down 80.03% at $1.33 during premarket trading on Wednesday. The stock is trading near its 52-week low of $0.19, according to Benzinga Pro data.

_Photo Courtesy: Proxima Studio on Shutterstock.com_

### Related Stocks

- [WOK.US](https://longbridge.com/en/quote/WOK.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [22119.HK](https://longbridge.com/en/quote/22119.HK.md)

## Related News & Research

- [WORK Medical Collaborates with Novabioplus to Unlock Biological Data Value with AI, Advancing the “BioToken” Assetization Model | WOK Stock News](https://longbridge.com/en/news/285950142.md)
- [A Look At UroGen Pharma (URGN) Valuation After New UGN-103 And ZUSDURI Bladder Cancer Data](https://longbridge.com/en/news/286722721.md)
- [Dyne Therapeutics Is Up 40%, but One Biotech Fund Just Disclosed Selling $14 Million Worth of Shares](https://longbridge.com/en/news/286950631.md)
- [Alaunos Reports Preclinical Aln1003 Data Showing Effects On Insulin-Resistance-Related Biomarkers And Liver Histology In Diet-Induced Obesity Models](https://longbridge.com/en/news/286776760.md)
- [Island Pharmaceuticals Strengthens Biodefence Engagement for Galidesivir Advancement](https://longbridge.com/en/news/286834766.md)